Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Burkitt Lymphoma 3Primary Myelofibrosis 2Neoplasms 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Depression 2Breast Neoplasms 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Urinary Incontinence 1Sezary Syndrome 1Sexual Dysfunction, Physiological 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Prostatic Hyperplasia 1

Interventions

Cisplatin 6Pemetrexed 4Carboplatin 3Nivolumab 2Ipilimumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1ranpirnase 1raltitrexed 1durvalumab 1atezolizumab 1Vinorelbine 1Vincristine 1Talc 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Platinum 1Mitomycin 1Injections 1Gemcitabine 1Fentanyl 1Drug Therapy 1Doxorubicin 1Cerebral Decortication 1Analgesia 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mesothelioma, Malignant × Psychiatric Rehabilitation × Clear all
NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 3 Completed
840 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡